Find information on thousands of medical conditions and prescription drugs.

Streptokinase

Streptokinase is an extracellular metallo-enzyme produced by beta-haemolytic streptococcus and is used as an effective and cheap clot-dissolving medication in some cases of myocardial infarction (heart attack) and pulmonary embolism. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
Growth hormone
Salbutamol
Salmeterol
Sandimmune
Sandostatin
Sansert
Saquinavir
Sarafem
Satric
Scopolamine
Seasonale
Secobarbital
Secretin
Selegiline
Semprex-D
Sensipar
Sensorcaine
Serax
Serevent
Serine
Seroquel
Serostim
Serrapeptase
Sertindole
Sertraline
Serzone
Sevelamer
Sevoflurane
Sibutramine
Sildenafil
Silibinin
Simvastatin
Sinemet
Sinequan
Singulair
Sirolimus
Skelaxin
Sodium cyclamate
Solage
Soma
Somatostatin
Sotahexal
Sotalol
Sotret
Spiperone
Spiriva
Spironolactone
Sporahexal
Sporanox
SPS
SSD
Stanozolol
Stavudine
Stelazine
Stilbestrol
Stilbetin
Stimate
Stiripentol
Strattera
Streptokinase
Streptomycin
Suboxone
Subutex
Sucralfate
Sucralfate
Sufentanil
Sulbactam
Sulfamethoxazole
Sulfanilamide
Sulfasalazine
Sulforidazine
Sulla
Sulpiride
Sultamicillin
Sumatriptan
Suprefact
Suramin sodium
Sustaire
Sustiva
Suxamethonium chloride
Symmetrel
Synarel
Synercid
Synthroid
Syntocinon
Zaleplon
T
U
V
W
X
Y
Z

It belongs to a group of medicines known as fibrinolytics, and works by cleaving plasminogen and producing plasmin.

Plasmin is produced in the blood to break down the major constituent of blood clots fibrin, therefore dissolving clots once they have fulfilled their purpose in stopping bleeding. Extra production of plasmin caused by streptokinase breaks down unwanted blood clots, for example, in the lungs (pulmonary embolism).

It is given intravenously as soon as possible after the onset of a heart attack (acute phase - myocardial infarction) to dissolve clots in the arteries of the heart wall. This reduces the amount of damage to the heart muscle. Streptokinase is a bacterial product so the body will build up an immunity to it. It is recommended that this medicine should not be used again after four days from the first administration, as it may not be as effective and can also cause an allergic reaction. For this reason, it is usually given only for a person's first heart attack.

Read more at Wikipedia.org


[List your site here Free!]


Low-molecular-weight heparin may aid acute MI: reviparin improved patient outcomes in thrombolysis with streptokinase or urokinase.(Cardiovascular Medicine) : An article from: Family Practice News $5.95 Indigenous recombinant streptokinase Vs natural streptokinase in acute myocardial infarction patients: Phase III multicentric randomized double blind trial.(Original ... from: Indian Journal of Medical Sciences $5.95
Streptokinase in chronic arterial disease $275.00 Thrombolytic therapy in acute myocardial infarction
Domain interactions between streptokinase and plasminogen Regulation of the streptokinase-plasmin(oge n) activator complex
Thrombolysis in a Rabbit Stroke Model Using Liposomal-Encapsulated Streptokinase

Evaluation of intrapleural streptokinase failure criteria used in MIST1 for the treatment of complicated pleural effusions
PURPOSE: Recently reported results in the New England Journal of Medicine from the Multicenter Intrapleural Sepsis Trial (MIST1) showed that intrapleural ...
Effect of intrapleural streptokinase administration on antistreptokinase antibody level in patients with loculated pleural effusions - clinical investigations
Background: Streptokinase is widely used IV for the treatment of myocardial infarction and intrapleurally for the treatment of loculated pleural effusions.
Ongoing Search for Effective Intrapleural Therapy for Empyema: Is Streptokinase the Answer?
Empyema is one of the oldest and severest of diseases, and drainage of pleural pus has always been regarded as the key to its successful management (1).
Intrapleural Streptokinase for Empyema and Complicated Parapneumonic Effusions
We conducted a single-center, randomized, placebo-controlled trial to determine whether streptokinase instillations adjunctive to chest tube drainage reduce the need for surgery and improve outcome i
Control of streptokinase gene expression in group A & C streptococci by two-component regulators
Background & objectives: Group A streptococci (GAS) and human isolates of group C streptococci (GCS) have the stable capacity to produce the plasminogen ...
Treatment of complicated parapneumonic pleural effusion with intrapleural streptokinase in children - clinical investigations
Objective: To evaluate the role of intrapleural streptokinase in the management of complicated parapneumonic effusions in children. Design: Prospective ...
Streptokinase for Endobronchial Blood Clots
To the Editor: Dr. Arney and colleagues (January 1999)[1] reported their experience with the management of endobronchial blood clots.[1] The authors ...
Intrapleural Streptokinase in the Management of Malignant Multiloculated Pleural Effusions - )
Objective: Pleural effusions are a frequent complication of malignancy and cause considerable morbidity from dyspnea. The drainage and control of malignant ...

Home Contact Resources Exchange Links ebay